Company / Accounts Receivable
Outset Medical, Inc. Accounts Receivable History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$28.3M
FY2025
5-year range
$25.6M / $35.6M
FY2021-FY2025
Trend
-20.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $33M to $28M over the past 2 years.
Based on SEC 10-K filings.
$28M in FY2025 with a 5-year CAGR of +34.4%.
Declined from $33M to $28M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +0.3%
- 5-Year CAGR
- +34.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +34.4%, indicating consistent growth.
- In FY2025, accounts receivable decreased 20.5% year-over-year.
- Peak accounts receivable was recorded in FY2024.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.88 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $28.3M | -20.5% |
| FY2024 | $35.6M | +8.0% |
| FY2023 | $33.0M | +17.5% |
| FY2022 | $28.1M | +9.6% |
| FY2021 | $25.6M | +295.8% |
| FY2020 | $6.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026